Jump to content

AstraZeneca share price: Q2 earnings preview


MongiIG

Recommended Posts

Astrazeneca Q2 revenue is expected to show strong growth, although an increased cost base will pressure underlying earnings.

AstraZenecaSource: Bloomberg
 
 Shaun Murison | Senior Market Analyst, Johannesburg | Publication date: Tuesday 27 July 2021 

When are the AstraZeneca results?

AstraZeneca, the biopharmaceutical company, earnings release date is scheduled for 27 July 2021. The scheduled results will cover the groups second quarter (Q2) and half-year earnings.

What to expect from AstraZeneca results?

While a large Covid-19 vaccine rollout will have boosted revenue for the group, it would have done little for underlying earnings due to the company selling the product as a non-profit item.

Consensus estimates derived from Refinitiv data arrives at the following expectations for Q2 of 2021:

  • Revenue $7.530 billion (+20%) year on year (YoY)
  • Earnings before interest tax depreciation amortisation (EBITDA) $2.233 billion (-10.75% YoY)
  • Earnings per share (EPS) $0.93 (-3.01% YoY)

What is expected to be accretive to future earnings for the group (although may weigh in the short term) is the groups acquisition of biopharmaceutical business Alexion, which was concluded on 21 July 2021, shortly after the reporting quarter.

Find out more on how to buy, sell and short AstraZeneca shares

How to trade AstraZeneca results

A Refinitiv poll of 29 analysts maintain a long-term average rating of ‘buy’ for AstraZeneca (as of 26 July 2021), with 10 of these analysts recommending a strong buy, 16 recommending a buy, 1 hold, 1 sell and 1 strong sell recommendation on the stock.

AstraZeneca broker ratingsSource: IG

AstraZeneca share price – technical analysis view

AstraZeneca chartSource: IG charts

 

The share price of AstraZeneca continues to trade in an uptrend which has been in place since the beginning of 2021. The price has however started to correct from near-term highs.

Traders respecting the longer-term uptrend will prefer to keep a long bias to trades targeting a retest of the 8770 level, provided that the price does not move to break the confluence of both trend line and horizontal support at the 7800 level. A break of the 7800 level would instead suggest the uptrend to be broken.

In summary

  • AstraZeneca results are scheduled for release on 27 July 2021
  • Q2 revenue of $7.530 billion is expected
  • Q2 EBITDA of $2.223 billion is expected
  • EPS of $0.93 is expected
  • The average broker rating for AstraZeneca is ‘buy’
  • The share price of AstraZeneca is currently in a short term correction of a longer-term uptrend
Link to comment

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • General Statistics

    • Total Topics
      16,009
    • Total Posts
      76,726
    • Total Members
      63,941
    • Most Online
      7,522
      10/06/21 10:53

    Newest Member
    Jaswin
    Joined 19/09/21 14:25
  • Posts

    • Why would I want an arm full of toxic clone spike proteins when I've already had covid (as have over 40% of the UK adult population). ONS data shows 96% of UK adults have covid antibodies when only 55% were vaxxed therefore 40% at least had come into contact with covid though many would not have even noticed it. Covid spreads by aerosol so of course masks are useless and so just a sign of conformity. I stick to the science papers and never see the msm fake narrative.   Meanwhile new lab work finds evidence of vaccine ADE (but not brave enough to call it). Recipients of the Pfizer vaccine have 5 - 6 fold LOWER natural antibody count.  
    • Ok, I just hope that you are consequent with your own words and don't get the Covid vaccine or don't wear a mask when you are asked to.  I hope you are not like these folks: https://www.theguardian.com/media/2021/sep/15/fox-news-vaccines-testing-tucker-carlson I know... I know... the guardian... It is not right-win biased.
    • Interesting data from the latest weekly PHE covid report download (as highlighted in the 'UK Vaccination Programme Part 1'. (article linked several posts above)   Attendance to emergency care and deaths from Covid (Delta)   6 months 1 Feb to 29 Aug 2021Unvaxxed     219,716Vaxxed         222,693     (27,993 + 80,877 + 113,823)   So obviously the vaccines do nothing to reduce infection and illness.But when looking at deaths alone the vaxxed are worse off. 68 per cent of covid deaths when including the partially ‘vaccinated’; while the ‘unvaccinated’ made up less than 30 per cent, when the vaxxed are less than 60% of the population.   So the Vaccines don't work they just make things worse. Reminder that when the drug companies said their vaccines had an efficacy of 95% what they meant was the difference between 0.88% (next to nothing) and 0.04% (also next to nothing). But that was against the now extinct Alpha not the now dominant vaccine resistant Delta (and all subsequent variants).   https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1014926/Technical_Briefing_22_21_09_02.pdf
×
×
  • Create New...